Picrasidine QCAS# 101219-61-8 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 101219-61-8 | SDF | Download SDF |
PubChem ID | 54714262 | Appearance | Yellow powder |
Formula | C15H10N2O3 | M.Wt | 266.3 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | COC1=C(C2=NC=CC3=C2N(C1=O)C4=CC=CC=C34)O | ||
Standard InChIKey | HJFNTSGIQCFHGP-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H10N2O3/c1-20-14-13(18)11-12-9(6-7-16-11)8-4-2-3-5-10(8)17(12)15(14)19/h2-7,18H,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Picrasidine Q has the capacity of anti-cell transformation and anti-cancer, it might be a chemopreventive and chemotherapeutic agent by direct targeting FGFR2 and inhibiting cell proliferation of ESCC cells. |
Targets | FGFR2 | PI3 K | AKT | mTOR |
Kinase Assay | FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.[Pubmed: 28857247]Journal of Cellular Biochemistry, 2017, 119(2).Fibroblast growth factor receptor (FGFR) 2 and its downstream signaling cascades, PI3 K/AKT/mTOR is playing an important role in cell survival and proliferations.
|
Picrasidine Q Dilution Calculator
Picrasidine Q Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.7552 mL | 18.7758 mL | 37.5516 mL | 75.1033 mL | 93.8791 mL |
5 mM | 0.751 mL | 3.7552 mL | 7.5103 mL | 15.0207 mL | 18.7758 mL |
10 mM | 0.3755 mL | 1.8776 mL | 3.7552 mL | 7.5103 mL | 9.3879 mL |
50 mM | 0.0751 mL | 0.3755 mL | 0.751 mL | 1.5021 mL | 1.8776 mL |
100 mM | 0.0376 mL | 0.1878 mL | 0.3755 mL | 0.751 mL | 0.9388 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- IRAK inhibitor 4
Catalog No.:BCC1657
CAS No.:1012104-68-5
- CUDC-101
Catalog No.:BCC2149
CAS No.:1012054-59-9
- Longipedlactone J
Catalog No.:BCN6644
CAS No.:1011762-93-8
- Momordicoside P
Catalog No.:BCN3275
CAS No.:1011726-62-7
- Tenovin-6
Catalog No.:BCC3667
CAS No.:1011557-82-6
- Odoriflavene
Catalog No.:BCN8240
CAS No.:101153-41-7
- Milnacipran HCl
Catalog No.:BCC4922
CAS No.:101152-94-7
- 3,8'-Biapigenin
Catalog No.:BCN5825
CAS No.:101140-06-1
- Tenovin-3
Catalog No.:BCC3889
CAS No.:1011301-27-1
- Larixinol
Catalog No.:BCN6484
CAS No.:101046-79-1
- Microcystin-LR
Catalog No.:BCC5339
CAS No.:101043-37-2
- MK-5108 (VX-689)
Catalog No.:BCC2176
CAS No.:1010085-13-8
- IRAK inhibitor 3
Catalog No.:BCC1656
CAS No.:1012343-93-9
- Kushenol K
Catalog No.:BCN3448
CAS No.:101236-49-1
- Kushenol L
Catalog No.:BCN3309
CAS No.:101236-50-4
- Kushenol M
Catalog No.:BCN3310
CAS No.:101236-51-5
- Phenserine
Catalog No.:BCC7529
CAS No.:101246-66-6
- 11-Chloro-2,3-dihydro-2-methyl-1H- dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
Catalog No.:BCC8431
CAS No.:1012884-46-6
- PETCM
Catalog No.:BCC2360
CAS No.:10129-56-3
- Noreugenin
Catalog No.:BCN5827
CAS No.:1013-69-0
- Zacopride hydrochloride
Catalog No.:BCC7178
CAS No.:101303-98-4
- PF-04691502
Catalog No.:BCC3837
CAS No.:1013101-36-4
- Formosanol
Catalog No.:BCN5826
CAS No.:101312-79-2
- Gadolinium chloride
Catalog No.:BCC7971
CAS No.:10138-52-0
FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.[Pubmed:28857247]
J Cell Biochem. 2018 Feb;119(2):2231-2239.
Fibroblast growth factor receptor (FGFR) 2 and its downstream signaling cascades, PI3 K/AKT/mTOR is playing an important role in cell survival and proliferations. In this study, we firstly found that Picrasidine Q (PQ), an alkaloid component extracted from Angelica keiskei species, has the capacity of anti-cell transformation and anti-cancer. After ligand shape similarity approach of PQ, we found that PQ targeted FGFR 2 and verified by FGFR2 kinase assay as well as computational docking model. FGFR2 highly expressed in esophageal cancer tissues and PQ inhibited fibroblast growth factor (FGF)-induced cell transformation. Furthermore, PQ inhibited cell proliferation and induced cell cycle arrest and apoptosis in KYSE30, KYSE410, and KYSE450 esophageal squamous cell carcinoma (ESCC) cells. It was confirmed by detecting of biological markers such as cyclinD1, cyclinD3 and cyclinB1 for cell cycle or cleaved caspase-7, caspase-3, and PARP for apoptosis. PQ targeting of FGFR2 kinase activities suppressed downstream target proteins including phosphorylation of AKT and mTOR but not MEK/ERK signaling pathways. Taken together, our results are the first to identify that PQ might be a chemopreventive and chemotherapeutic agent by direct targeting FGFR2 and inhibiting cell proliferation of ESCC cells.